216 related articles for article (PubMed ID: 28604387)
1. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.
Scholl UI; Abriola L; Zhang C; Reimer EN; Plummer M; Kazmierczak BI; Zhang J; Hoyer D; Merkel JS; Wang W; Lifton RP
J Clin Invest; 2017 Jun; 127(7):2739-2750. PubMed ID: 28604387
[TBL] [Abstract][Full Text] [Related]
2. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
[TBL] [Abstract][Full Text] [Related]
3. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
4. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
[TBL] [Abstract][Full Text] [Related]
5. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
[TBL] [Abstract][Full Text] [Related]
6. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
[TBL] [Abstract][Full Text] [Related]
7. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
Monticone S; Hattangady NG; Nishimoto K; Mantero F; Rubin B; Cicala MV; Pezzani R; Auchus RJ; Ghayee HK; Shibata H; Kurihara I; Williams TA; Giri JG; Bollag RJ; Edwards MA; Isales CM; Rainey WE
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1567-72. PubMed ID: 22628608
[TBL] [Abstract][Full Text] [Related]
8. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Tauber P; Penton D; Stindl J; Humberg E; Tegtmeier I; Sterner C; Beuschlein F; Reincke M; Barhanin J; Bandulik S; Warth R
Endocrinology; 2014 Apr; 155(4):1353-62. PubMed ID: 24506072
[TBL] [Abstract][Full Text] [Related]
10. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM
J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
Kitamoto T; Suematsu S; Yamazaki Y; Nakamura Y; Sasano H; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Clin Endocrinol Metab; 2016 Feb; 101(2):494-503. PubMed ID: 26606680
[TBL] [Abstract][Full Text] [Related]
14. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
[TBL] [Abstract][Full Text] [Related]
15. Different cell compositions and a novel somatic
Zhao L; Wan J; Wang Y; Yang W; Liang Q; Wang J; Jin P
Front Endocrinol (Lausanne); 2023; 14():1068335. PubMed ID: 36960396
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
Azizan EA; Murthy M; Stowasser M; Gordon R; Kowalski B; Xu S; Brown MJ; O'Shaughnessy KM
Hypertension; 2012 Mar; 59(3):587-91. PubMed ID: 22252394
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
[TBL] [Abstract][Full Text] [Related]
18. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
19. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
[TBL] [Abstract][Full Text] [Related]
20. NEFM (Neurofilament Medium) Polypeptide, a Marker for Zona Glomerulosa Cells in Human Adrenal, Inhibits D1R (Dopamine D1 Receptor)-Mediated Secretion of Aldosterone.
Maniero C; Garg S; Zhao W; Johnson TI; Zhou J; Gurnell M; Brown MJ
Hypertension; 2017 Aug; 70(2):357-364. PubMed ID: 28584012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]